CD44 Splice Variant Expression in Clear Cell Carcinoma of the Ovary
Open Access
- 1 November 1998
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 71 (2) , 223-229
- https://doi.org/10.1006/gyno.1998.5108
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Steroidogenesis-Inducing Protein, Isolated from Human Ovarian Follicular Fluid, Is a Potent Mitogen for Cell Lines Derived from Ovarian Surface Epithelial CarcinomasGynecologic Oncology, 1997
- Immunohistochemical Detection of CD44 Splice Variant Expression in Premalignant Lesions of the Cervix and Benign Cervical EpitheliumGynecologic Oncology, 1997
- CD44: Structure, Function and Association with the Malignant ProcessPublished by Elsevier ,1997
- CD44 standard and variant isoform expression in human epidermal skin tumors is not correlated with tumor aggressiveness but down-regulated during proliferation and tumor de-differentiationInternational Journal of Cancer, 1996
- Immunohistochemical and serological evaluation of CD44 splice variants in human ovarian cancerBritish Journal of Cancer, 1995
- Prognostic Value of CD44 Splice Variant Expression in Ovarian CancerOncology, 1995
- Expression and modulation of CD44 variant isoforms in humansThe Journal of cell biology, 1994
- A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps.The Journal of cell biology, 1993
- Cancer metastasis and angiogenesis: An imbalance of positive and negative regulationCell, 1991
- CD44 is the principal cell surface receptor for hyaluronateCell, 1990